Mature Presbyopes Clinical Research Update Presented at Global Specialty Lens Symposium (GSLS)

LAS VEGAS--(BUSINESS WIRE)--US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) presented at the Global Specialty Lens Symposium (GSLS) an update of clinical data with mature presbyopes, those patients with > +1.75 ADD power and over 55 years of age. Contact lenses to address presbyopia (true bifocals) have been in existance since the late 1940’s, however, o

Full Story →